ERBB2 and neoplasm: Nevertheless, retargeting by ErbB2-targeted CAR-expressing NK cell or high affinity FcR transgenic NK cells plus monoclonal antibody Herceptin (ADCC) provides signals necessary to achieve granule polarization and tumor cell lysis, thereby circumventing tumor cell resistance [103].